Alginate and Etoposide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Alginate (algin) and Etoposide (etoposide). Common drug interactions include hypokalaemia among females and chronic graft versus host disease among males.

The phase IV clinical study analyzes what interactions people have when they take Alginate and Etoposide. It is created by eHealthMe based on reports of 16 people who take the same drugs from the FDA, and is updated regularly.

What is Alginate?

Alginate has active ingredients of algin. eHealthMe is studying from 1,556 Alginate users. Check the latest studies of Alginate.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

On Jul, 11, 2026

16 people who take Alginate and Etoposide together, and have interactions are studied.

Alginate and Etoposide drug interactions.

What are the common drug interactions of Alginate and Etoposide, by gender? *:

female:

Hypokalaemia (low potassium)
Death
Constipation
Hyperglycaemia (high blood sugar)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Hyperthyroidism (over activity of the thyroid gland)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Fatigue (feeling of tiredness)
Palpitations (feelings or sensations that your heart is pounding or racing)

male:

Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
Diarrhoea
Graft versus host disease in skin (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the skin)
Hypertriglyceridaemia (excess of triglycerides in the blood)
Obliterative bronchiolitis (bronchiolar inflammation)
Pyrexia (fever)
Septic shock (shock due to blood infection)
Transient ischaemic attack (a transient episode of neurologic dysfunction caused by ischemia (loss of blood flow))
Abdominal pain
Abdominal pain upper

What are the common drug interactions of Alginate and Etoposide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

Chronic graft versus host disease (immune cells attack the host's body cells after transplant)
Diarrhoea
Hypertension (high blood pressure)
Stomatitis (inflammation of mucous membrane of mouth)
Acute lymphocytic leukaemia recurrent (cancer in which the bone marrow makes too many lymphocytes-recurrent)
Capillary leak syndrome (capillary leaks plasma)
Cystitis haemorrhagic (blood in the urine and painful voiding)
Engraft failure
Gastritis (inflammation of stomach)
Graft versus host disease in intestine (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body and damages intestinal mucosal membrane)

20-29:

n/a

30-39:

n/a

40-49:

Hypokalaemia (low potassium)
Palpitations (feelings or sensations that your heart is pounding or racing)
Sinus tachycardia (a heart rhythm with elevated rate of impulses originating from the sinoatrial node)
Death
Constipation
Hyperglycaemia (high blood sugar)
Angina pectoris (chest pain due to ischemia of the heart muscle)
Hyperthyroidism (over activity of the thyroid gland)
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood)
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)

50-59:

n/a

60+:

General physical health deterioration (weak health status)

What are the existing conditions these people have? *

Cancer Pain: 9 people, 56.25%
Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 8 people, 50.00%
Adverse Event: 7 people, 43.75%
Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 5 people, 31.25%
Bone Marrow Conditioning Regimen: 5 people, 31.25%
Graft Versus Host Disease (the donated bone marrow or stem cells view the recipient's body as foreign, and the donated cells/bone marrow attack the body): 3 people, 18.75%
Pneumonia: 3 people, 18.75%
Capillary Leak Syndrome (capillary leaks plasma): 3 people, 18.75%
Diarrhea: 3 people, 18.75%
Small Cell Lung Cancer Metastatic (lung cancer spreads to other body parts): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Alginate and Etoposide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously